Results 321 to 330 of about 2,542,870 (405)

Opioid Analgesia Following Pediatric Adenotonsillectomy: A Randomized Clinical Trial

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To compare the safety and efficacy of nonopioid versus opioid pain management following adenotonsillectomy (AT) among pediatric patients. Study Design An open‐label randomized controlled trial. Setting Tertiary care children's hospital. Methods Patients aged 3 to 17 years undergoing AT were eligible.
Rachel L. Whelan   +13 more
wiley   +1 more source

Differential temporal decline of cerebral oxytocin and μ-opioid receptor density during the aging process in mice. [PDF]

open access: yesEur J Neurosci
Effah F   +6 more
europepmc   +1 more source

Steroids for Pediatric Adenotonsillectomy Pain—A Prospective Multicenter Randomized Trial

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To compare postoperative caregiver‐reported pain control of two steroid regimens following pediatric adenotonsillectomy. Secondary objectives assessed differences in analgesic use, return to normal diet, caregiver calls, adverse effects, and emergency room (ER) visits. Study Design Prospective randomized pragmatic trial.
Kevin D. Pereira   +7 more
wiley   +1 more source

Post‐COVID‐19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategies

open access: yesThe Journal of Pathology, EarlyView.
Abstract Post‐COVID‐19 condition (PCC), also known as long COVID, is a complex multiple organ system condition that can develop and persist for months after acute COVID‐19. PCC encompasses a wide range of symptoms, resulting in heterogeneous clinical manifestations. These manifestations likely arise from diverse underlying pathophysiological mechanisms,
Larissa E Vlaming‐van Eijk   +5 more
wiley   +1 more source

Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
Abstract Background Oxaliplatin‐induced peripheral neuropathy (OIPN) is a major clinical challenge because it leads to discontinuation of chemotherapy. Omeprazole, a proton pump inhibitor (PPI), has been shown to prevent OIPN in a rat model. Therefore, we aimed to test whether the concomitant use of a PPI reduces oxaliplatin discontinuation due to OIPN.
Keisuke Mine   +14 more
wiley   +1 more source

Who Gets Referred to School‐Based Trauma Treatment? A Descriptive Analysis of Bounce Back and Support for Students Exposed to Trauma

open access: yesPsychology in the Schools, EarlyView.
ABSTRACT This study describes one district's experience having counselors deliver, for the first time, a school‐based treatment to address student trauma symptoms. After their initial training, school counselors rated Bounce Back (K‐5th grade) and Support for Students Exposed to Trauma (5th−12th grade) as highly acceptable and anticipated a positive ...
Yourdanos Bekele   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy